InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Cardiol Therapeutics Inc.

CRDL Clue Score36
Ontario, Canada Fiscal year ends December CIK 0001702123
$1.20 +1.69% Close, 13 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.20 −65.01% Close, 13 Oct 2026

Closing prices at the end of each trading day, from 15 Jan 2019. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2020Operating income−20.7Net income−20.6EPS, diluted−0.69Fiscal year 2021Revenue0.1Operating income−38.7Net income−31.6EPS, diluted−0.73Fiscal year 2022Operating income−41.3Net income−30.9EPS, diluted−0.49Fiscal year 2023Operating income−29.8Net income−28.1EPS, diluted−0.44Fiscal year 2024Operating income−40.3Net income−36.7EPS, diluted−0.51Fiscal year 2025Operating income−34.3Net income−33.8EPS, diluted−0.39
FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a 0.1 n/a n/a n/a n/a
Growth
Operating income −20.7 −38.7 −41.3 −29.8 −40.3 −34.3
Net income −20.6 −31.6 −30.9 −28.1 −36.7 −33.8
Growth
EPS, diluted −0.69 −0.73 −0.49 −0.44 −0.51 −0.39
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2020Fiscal year 2021Operating margin−49,091.9%Net margin−40,170.4%Free cash flow margin−29,904.2%Fiscal year 2022Fiscal year 2023Fiscal year 2024Fiscal year 2025
FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a −49,091.9% n/a n/a n/a n/a
Net margin n/a −40,170.4% n/a n/a n/a n/a
Free cash flow margin n/a −29,904.2% n/a n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2020Operating cash flow−9.1Capital expenditure−0.0Free cash flow−9.2Fiscal year 2021Operating cash flow−23.5Capital expenditure−0.0Free cash flow−23.6Fiscal year 2022Operating cash flow−27.2Capital expenditure−0.1Free cash flow−27.3Fiscal year 2023Operating cash flow−25.2Capital expenditure−0.1Free cash flow−25.2Fiscal year 2024Operating cash flow−25.1Capital expenditure−0.0Free cash flow−25.1Fiscal year 2025Operating cash flow−23.9Capital expenditure−0.0Free cash flow−23.9
FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −9.1 −23.5 −27.2 −25.2 −25.1 −23.9
Capital expenditure −0.0 −0.0 −0.1 −0.1 −0.0 −0.0
Free cash flow −9.2 −23.6 −27.3 −25.2 −25.1 −23.9
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash and securities
Fiscal year 2020Cash and securities14.0Shareholders’ equity13.3Fiscal year 2021Cash and securities83.9Shareholders’ equity76.2Fiscal year 2022Cash and securities59.5Shareholders’ equity52.2Fiscal year 2023Cash and securities34.9Shareholders’ equity28.2Fiscal year 2024Cash and securities30.6Shareholders’ equity24.7Fiscal year 2025Cash and securities21.4Shareholders’ equity17.9
FY2020FY2021FY2022FY2023FY2024FY2025
Cash and securities 14.0 83.9 59.5 34.9 30.6 21.4
Shareholders’ equity 13.3 76.2 52.2 28.2 24.7 17.9

In millions of CAD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of CAD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
−9.1 −23.5 −27.2 −25.2 −25.1 −23.9
Growth
Investment
−0.0 −0.0 −0.1 −0.1 −0.0 −0.0
calc −9.2 −23.6 −27.3 −25.2 −25.1 −23.9
Growth
calc −0.31 −0.54 −0.44 −0.39 −0.35 −0.27
−0.0 −0.0 −0.1 −0.1 −0.0 −0.0
Financing
16.3 93.4 −0.1 −0.1 18.8 15.5

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative. Shown in CAD as filed; the screener converts to dollars.